Gary C. Evans, Director at NOVAVAX INC (NVAX), sold 24,500 shares at $210.00 ($5.2M) on 2021-03-15, disclosed to the SEC on 2021-03-17.
Open-market sale of $5.2M NVAX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $210.00 | 9,732 | $2.0M | 39.5% |
| 2 | $212.00 | 14,768 | $3.1M | 60.5% |
| Total | $211.21 avg | 24,500 | $5.2M | 100% |
| Filing → |
| UAMY | BUY | 2024-12-11 | $290K | — | Filing → |
| UAMY | BUY | 2023-01-20 | $10K | — | Filing → |
| UAMY | BUY | 2023-01-17 | $14K | — | Filing → |